PIROXICAM Drug Record

  • PIROXICAM CHEMBL527 FDA Approved

    Alternate Names:

    Piroflam 10
    Brexidol
    Flamatrol
    Larapam
    Piroxicam
    Piroflam 20
    Pirozip 10
    Pirozip 20
    Kentene
    Feldene P
    Feldene 20
    Feldene
    CP-16171
    C751
    178103847
    7273
    BRUXICAM
    RIACEN
    PIROXICAM USP
    ROXICAM
    0378-1010-01
    FLOGOBENE
    4761
    PIROFLEX
    SOLOCALM
    PIRKAM
    ZUNDEN
    ARTROXICAM
    SASULEN
    PA450985
    CN1C(=C(C2CCCCC2S1(=O)=O)O)C(=O)NC3CCCCN3
    BAXO
    AKTEN
    IMPRONTAL
    DB00554
    ERAZON
    AK1015
    C01608
    CALIMENT
    5280452
    APO-PIROXICAM
    8249
    DAP000181
    GELDENE
    ROXIDEN
    REUDENE
    658839
    D00127
    PIPOXICAM
    F0001-2399
    W-106626
    3B2-0151
    AB00052074-22
    AB00052074-21
    M-9898
    J10253
    A19556
    EN300-70724
    P1905
    FT-0630590
    FT-0080892
    TR-014899
    ST2411449
    KB-284635
    CAS_36322-90-4
    AJ-111664
    AB2000240
    AB0011706
    BCP0726000299
    ST069379
    NCI60_022912
    HE418346
    HE338394
    HE168177
    DR001567
    BC204217
    AK142892
    NCGC00257705-01
    NCGC00188982-01
    NCGC00021244-09
    NCGC00021244-08
    NCGC00021244-07
    NCGC00021244-06
    NCGC00021244-05
    NCGC00021244-03
    NCGC00015823-18
    NCGC00015823-17
    NCGC00015823-15
    NCGC00015823-14
    NCGC00015823-13
    NCGC00015823-12
    NCGC00015823-11
    NCGC00015823-10
    NCGC00015823-09
    NCGC00015823-08
    NCGC00015823-07
    NCGC00015823-06
    NCGC00015823-05
    NCGC00015823-04
    NCGC00015823-03
    NCGC00015823-01
    IDI1_002110
    IDI1_000369
    PIROXICAM-SUPPLIED BY SELLECK CHEMICALS
    NSC-757284
    NSC-666076
    MCULE-1939282084
    LP00900
    KS-5322
    CS-2233
    AM84917
    TOX21_110231_1
    PIROXICAM [USAN:USP:INN:BAN:JAN]
    ZINC87724780
    ZINC51133897
    ZINC12466469
    NSC757284
    CCG-36403
    BBL016493
    ANW-43611
    TOX21_200151
    TOX21_110231
    NSC_4856
    HY-B0253
    PHARMAKON1600-01500491
    HMS3429L03
    HMS3403D11
    HMS3369B07
    HMS3267I03
    KBIO2_005506
    KBIO2_004163
    KBIO2_002938
    KBIO2_001595
    KBIO2_000370
    KBIO1_000369
    CTK7I2700
    BDBM85245
    BCBCMAP01_000176
    CHEMBL1518938
    SCHEMBL3703617
    GTPL7273
    BPBIO1_000245
    PIROXICAM (JP16/USP/INN)
    PIROXICAM (JP15/USP/INN)
    AMBAP36322-90-4
    SPBIO_002142
    SPBIO_001293
    DIVK1C_000369
    MLS004774122
    MLS001304054
    MLS001148207
    MLS000069644
    MLS000038002
    KBIOSS_001595
    KBIOSS_000370
    KBIOGR_001315
    KBIOGR_000370
    BSPBIO_002460
    BSPBIO_001030
    BSPBIO_000221
    SCHEMBL21350
    SCHEMBL13462
    OPREA1_714707
    LOPAC0_000900
    D010894
    BIDD:PXR0154
    13T4O6VMAM
    AC1L1J3Z
    LOPAC-P-5654
    SPECTRUM5_001445
    SPECTRUM4_000968
    SPECTRUM3_000780
    SPECTRUM2_001287
    PRESTWICK3_000211
    PRESTWICK2_000211
    PRESTWICK1_000211
    PRESTWICK0_000211
    AC1NSM2R
    TOCRIS-0960
    SPECTRUM_001115
    4-?HYDROXY-?2-?METHYL-?N-?2-?PYRIDINYL-?2H-?1,?2-?BENZOTHIAZINE-?3-?CARBOXAMIDE-?1,?1-?DIOXIDE
    3-[HYDROXY(PYRIDIN-2-YLAMINO)METHYLIDENE]-2-METHYL-3,4-DIHYDRO-2H-1$L^{6},2-BENZOTHIAZINE-1,1,4-TRIONE
    3-[HYDROXY(PYRIDIN-2-YLAMINO)METHYLIDENE]-2-METHYL-2,3-DIHYDRO-4H-1,2-BENZOTHIAZIN-4-ONE 1,1-DIOXIDE
    (Z)-3-(HYDROXY(PYRIDIN-2-YLAMINO)METHYLENE)-2-METHYL-2H-BENZO[E][1,2]THIAZIN-4(3H)-ONE 1,1-DIOXIDE
    (E)-3-(HYDROXY(PYRIDIN-2-YLAMINO)METHYLENE)-2-METHYL-2,3-DIHYDRO-4H-BENZO[E][1,2]THIAZIN-4-ONE 1,1-DIOXIDE
    (3E)-3-{HYDROXY[(PYRIDIN-2-YL)AMINO]METHYLIDENE}-2-METHYL-3,4-DIHYDRO-2H-1|E?,2-BENZOTHIAZINE-1,1,4-TRIONE
    N-(2-PYRIDYL)-4-HYDROXY-2-METHYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE
    4-HYDROXY-2-METHYL-N-2-PYRIDINYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE1,1-DIOXIDE
    4-HYDROXY-2-METHYL-N-2-PYRIDINYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE
    4-HYDROXY-2-METHYL-3-(2-PYRIDYLCARBAMOYL)-2H-1,2-BENZOTHIAZINE 1,1-DIOXIDE
    4-HYDROXY-2-METHYL-1,1-DIOXO-N-PYRIDIN-2-YL-1LAMBDA6,2-BENZOTHIAZINE-3-CARBOXAMIDE
    4-HYDROXY-2-METHYL-1,1-DIOXO-N-(2-PYRIDYL)-1$L^{6},2-BENZOTHIAZINE-3-CARBOXAMIDE
    3,4-DIHYDRO-2-METHYL-4-OXO-N-2-PYRIDYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE
    2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE,4-HYDROXY-2-METHYL-N-2-PYRIDINYL-,1,1-DIOXIDE
    (4-HYDROXY-2-METHYL-1,1-DIOXOBENZO[E]1,2-THIAZIN-3-YL)-N-(2-PYRIDYL)CARBOXAMID E
    (3Z)-3-[HYDROXY-(PYRIDIN-2-YLAMINO)METHYLIDENE]-2-METHYL-1,1-DIOXO-1
    3-[HYDROXY-(PYRIDIN-2-YLAMINO)METHYLIDENE]-2-METHYL-1,1-DIOXO-1
    CID5280452
    PIROXICAM (FELDENE)
    ROXAM;FELDENE
    TRAST
    ROSIDEN
    DOLONEX
    FELDENEREG
    SMR000035997
    4-HYDROXY-2-METHYL-N-(PYRIDIN-2-YL)-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE
    4-HYDROXY-2-METHYL-N-(2-PYRIDYL)-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE
    (4-HYDROXY-2-METHYL-1,1-DIOXOBENZO[E]1,2-THIAZIN-3-YL)-N-(2-PYRIDYL)CARBOXAMIDE
    4-HYDROXY-2-METHYL-3[PYRID-2-YL-CARBAMOYL]-2H-1,2-BENZOTHIAZINE 1,1-DIOXIDE
    (3E)-3-[HYDROXY-(PYRIDIN-2-YLAMINO)METHYLIDENE]-2-METHYL-1,1-DIOXO-1
    3-[HYDROXY(PYRIDIN-2-YLAMINO)METHYLIDENE]-2-METHYL-3,4-DIHYDRO-2H-1
    DSSTOX_GSID_21170
    DSSTOX_RID_75990
    4-HYDROXY-2-METHYL-N-(2-PYRIDYL)-2H-1,2-BENZOTHIAZIN-3-CABOXYAMID-1,1-DIOXID [GERMAN]
    P 5654
    DSSTOX_CID_1170
    EU-0100900
    CAS-36322-90-4
    BAS 04381594
    AC-12216
    NCGC00015823-02
    LS-7663
    AKOS000714958
    4-HYDROXY-2-METHYL-N-PYRIDIN-2-YL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE
    STK177288
    4-HYDROXY-2-METHYL-N-2-PYRIDYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE
    4-HYDROXY-2-METHYL-N-(2-PYRIDYL)-2H-1,2-BENZOTHIAZIN-3-CABOXYAMID-1,1-DIOXID
    4-HYDROXY-2-METHYL-3-(PYRID-2-YL-CARBAMOYL)-2H-1,2-BENZOTHIAZINE 1,1-DIOXIDE
    HMS2092A05
    HMS1990D11
    HMS1920H22
    HMS1792D11
    HMS1568L03
    HMS1362D11
    QYSPLQLAKJAUJT-UHFFFAOYSA-N
    PIROXICAM [USAN:BAN:INN:JAN]
    MOLPORT-001-888-120
    HMS501C11
    P0847_SIAL
    SPECTRUM1500491
    BIO-0759
    4-HYDROXY-2-METHYL-N-(2-PYRIDYL)-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE-1,1-DIOXIDE
    BRN 0627692
    FELDENE, ROXAM, PIROXICAM
    NSC666076
    EINECS 252-974-3
    4-HYDROXY-2-METHYL-N-(PYRIDIN-2-YL)-2H-BENZO[E][1,2]THIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE
    2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE, 4-HYDROXY-2-METHYL-N-2-PYRIDINYL-, 1,1-DIOXIDE
    AC1Q3XLJ
    AC1NQX1P
    C15H13N3O4S
    S1713_SELLECK
    CHEBI:8249
    CCRIS 3719
    NSC 666076
    PRESTWICK_573
    FELDENE (TN)
    CHF 1251
    UNII-13T4O6VMAM
    PIROXICAMUM [INN-LATIN]
    FELDENE GEL
    FELDENE FAST
    ROXAM
    FELDEN
    HMS3262D22
    HMS2231G03
    HMS2095L03
    HMS2089B06
    BIO2_000835
    BIO2_000355
    BIO1_001341
    BIO1_000852
    BIO1_000363
    NINDS_000369
    MOLPORT-035-874-705
    MOLPORT-016-636-421
    KBIO3_001680
    KBIO3_000720
    KBIO3_000719
    KBIO2_006731
    PIROXICAMUM
    PIROFTAL
    PYROXYCAM
    36322-90-4
    54676228
    Therafeldamine
    Teva-piroxicam
    Rho-piroxicam - Cap 20mg
    Rho-piroxicam - 10mg Cap
    Pro-piroxicam Cap 20mg
    Pro-piroxicam Cap 10mg
    Piroxicam Capsules 20mg
    Piroxicam Capsules 10mg
    Penta-piroxicam Capsules
    PMS-piroxicam Suppositories-10mg
    PMS-piroxicam Suppositories -20mg
    PMS-piroxicam
    Nu-pirox Cap 20mg
    Nu-pirox Cap 10mg
    Gen-piroxicam-cap 10mg
    Gen-piroxicam - Cap 20mg
    Geldène
    Fexicam
    Feldene Sup 20mg
    Feldene Sup 10mg
    Feldene Cap 20mg
    Feldene Cap 10mg
    Dom-piroxicam
    Apo Piroxicam Cap 20mg
    Apo Piroxicam Cap 10mg
    Alti-piroxicam-cap 20mg
    Alti-piroxicam-cap 10mg

    Drug Info:

    Year of Approval 1982
    Drug Class anti-inflammatory agents, non-steroidal
    Drug Type drug/small molecule
    ATC m02aa(antiinflammatory preparations
    ATC s01bc(antiinflammatory agents
    ATC m01ac(oxicams)
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications antiinflammatory agent,NSAID
    Drug Categories thiazines
    Drug Categories therapeutic uses
    Drug Categories sulfur compounds
    Drug Categories sensory system agents
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories peripheral nervous system agents
    Drug Categories oxicams
    Drug Categories organic chemicals
    Drug Categories musculo-skeletal system
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories inorganic chemicals
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories enzyme inhibitors
    Drug Categories cytochrome p-450 cyp2c9 substrates
    Drug Categories cytochrome p-450 cyp2c9 inhibitors
    Drug Categories cytochrome p-450 cyp2c8 substrates
    Drug Categories cytochrome p-450 cyp2c8 inhibitors
    Drug Categories cyclooxygenase inhibitors
    Drug Categories chemical actions and uses
    Drug Categories central nervous system agents
    Drug Categories antirheumatic agents
    Drug Categories antiinflammatory and antirheumatic products, non-steroids
    Drug Categories antiinflammatory and antirheumatic products
    Drug Categories anti-inflammatory agents, non-steroidal
    Drug Categories anti-inflammatory agents
    Drug Categories analgesics, non-narcotic
    Drug Categories analgesics
    Drug Groups investigational
    Drug Groups approved
    Drug Type small molecule
    (6 More Sources)

    Publications:

    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Raju et al., 2002, Differential modulation of transforming growth factor-betas and cyclooxygenases in the platelet lysates of male F344 rats by dietary lipids and piroxicam., Mol. Cell. Biochem.
    Bugajski et al., 2001, Involvement of constitutive (COX-1) and inducible cyclooxygenase (COX-2) in the adrenergic-induced ACTH and corticosterone secretion., J. Physiol. Pharmacol.
    Veiga et al., 2004, Prevention by celecoxib of secondary hyperalgesia induced by formalin in rats., Life Sci.
    Blanco et al., 1999, Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes., J. Rheumatol.
    Fackovcova et al., 2000, Renal damage induced by the treatment with non-opioid analgesics--theoretical assumption or clinical significance., Bratisl Lek Listy
    Kocaoğlu et al., 1997, Urinary gamma-glutamyl transferase activity in rats with nonsteroidal anti-inflammatory drug-induced nephrotoxicity., Arch. Immunol. Ther. Exp. (Warsz.)
    Halberg et al., 2000, Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers., Proc. Natl. Acad. Sci. U.S.A.